Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

II.e

ARDS - Acute lung injury

Publications

Gower J, Labarca G, Enos D, Nova-Lamperti E

Rapid development of severe acute respiratory distress syndrome after abatacept treatment in a patient with rheumatoid arthritis.

BMJ case reports 2020 Apr 06;13; — 2020 Apr 06

Do?u B, Atilla N, Çetin GY, Y?lmaz N, Öksüz H

A case of acute respiratory failure in a rheumatoid arthritis patient after the administration of abatacept.

European journal of rheumatology 2016 Sep;3;134-135 — 2016 Sep — 134-135